For some experiments, bone marrow cells were enriched for progenitor cells using mAbs against the CD34 and HLA-DR antigens, followed by FAGS. Monocyte-and T cell-depleted light density bone marrow cells (2.5 x 106 cells/ml) were preincubated with 5% rabbit serum to prevent nonspecific Fc binding followed by incubation with 20 jug/ml anti-CD34 (MY10) mAb (Becton Dickinson & Co.). Cells were labeled with GAM-FITC (6 lLg/ml) and incubated with Iscove's modified Dulbeccds medium (IMDM) containing 50% mouse serum in order to block nonspecific binding of the subsequent antibodies. Next, cells were incubated with 1.3 p,g/ml anti-HLA-DR antibody conjugated to phycoerythrin (Becton Dickinson & Co.). CD34*HLA-DR' cells were sorted using a FACStar (argon-ion laser tuned at 488 nm, Becton Dickinson & Co.). From the HLA-DR' cells, presenting as a separate cluster, the CD34' cells were isolated . The cut-off point was chosen after the first log decade, based on the fluorescence intensity of a control sample stained with the GAM-FITC-labeled antibody only.
BFU-E Cultures. Bone marrow progenitor cells were cultured as described (6, 7) . Light density bone marrow cells were cultured at a concentration of 105/ml in IMDM containing 20% FCS, 5 x 10-5 M 2-ME, 0.5 g/liter deionized BSA, 0.47 g/liter human transferrin (Behringwerke AG, Marburg, Federal Republic of Germany), 10-5 FeC13-6H20, and 0.98% methylcellulose (Methocel, Oud Beyerland, The Netherlands). Colony formation was stimulated with purified human EPO (1 U/ml; kindly provided by Organon Teknika BV, Turnhout, Belgium) and either human rGM-CSF (50 U/ml; a gift ofthe Schering Corp.), or human rM-CSF (a gift of Dr. P Ralph; Cetus Corp., Emeryville, CA) . 100,ul/well was plated in sixfold in flat-bottomed microtiter plates (Greiner, Alphen a/d Rijn, The Netherlands) . Growth of the relatively mature erythroid colony forming units (CFU-E, compact clusters of 8-64 erythroid cells) was scored on day 7 . The more immature erythroid burst forming units (BFU-E), granulocyte colony forming units (CFU-G, clusters of >50 granulocytis) and CFU-M (clusters of >20 macrophages) were scored on day 14.
CFU-GM Cultures. Monocyte-and T cell-depleted light density bone marrow cells were cultured at a concentration of 0.5 x 105 cells/ml. CD34'HLA-DR' cells were cultured at a concentration of 104 cells/ml. Cells were cultured in a-MEM containing 207o FCS and 0.96% methylcellulose . Colony growth was stimulated with 50 U/ml human rGM-CSF. 100 pl/well was plated in sixfold in flat-bottomed microtiter plates . CFU-G and CFU-M colonies were scored on day 14.
Cultures were kept in a fully humidified 5% C02 atmosphere at 37°C. After the culture period, colonies were scored with an inverted microscope and, in some experiments, massharvested or picked individually with a micropipette, spread on microscope slides, and stained with ANAE or May-Grunwald Giemsa to confirm the monocytic or granulocytic lineage .
Results
Light Density Bone Marrow Cells. To study the influence of IL-4 on colony formation by human bone marrow progenitor cells, we added increasing concentrations of human HL-4 to cultures oflight density bone marrow cells stimulated with human rGM-CSF and EPO. A dose-dependent inhibition of macrophage colony formation was observed in bone marrow cultures offive successive donors ( Fig. 1) . At a concentration of 5 ng IL-4/ml, macrophage colony growth was reduced to ± 20% of control values . In contrast, erythroid (CFU-E and BFU-E) and granulocytic colony growth were not affected by IL-4.
Role ofAccessory Cells. To study whether the IL-4-dependent inhibition of macrophage colony growth was mediated by accessory cell populations, we cultured monocyte-and T cell-depleted light density bone marrow cells stimulated with GM-CSR Again, IL-4 induced a dose-dependent inhibition ofmacrophage colony formation (Fig. 2 A) , suggesting that the effect was exerted directly on the hematopoietic progenitor cells. To further explore this, we cultured FAGS-sorted CD34+HLA-DR' cells stimulated with GM-CSF. A similar dose-dependent inhibition of macrophage colony formation by IL-4 was found, whereas granulocytic colony numbers were not reduced (Fig . 2 B) . Control Experiments. To confirm that the observed inhibition was due to IL-4 and not to a toxic contamination, we performed the following control experiments.
IL-4 was heat inactivated (20 min at 100°C) and added to the cultures at a concentration of 50 ng/ml. In all experiments (n = 8) the IL-4-induced inhibition of CFU-M was completely abrogated (data not shown) .
Human rIL-4 from another source, a nonglycosilated protein, was tested on monocyte-and T cell-depleted bone marrow cells. This IL-4 had a similar inhibitory effect on CFU-M growth (inhibition up to 9070) as the recombinant human glycosilated IL-4 preparation, at the same concentration of IL-4 as measured in an ELISA, courtesy of Dr. J. E. de Vries (data not shown) .
IL-4 was preincubated (1 h at 37°C) with increasing concentrations of anti-IL-4 antiserum. The observed effect on CFU-M colony growth could be completely abrogated by this antiserum in a dose-dependent fashion (Fig. 3) . M-CSF-stimulated Colony Formation. To study whether the inhibition of macrophage colony formation by IL-4 was dependent on the growth factor used to induce colony growth, increasing doses of IL-4 were added to monocyte-and T cell-depleted bone marrow cultures in which colony growth was induced with EPO and M-CSF. These experiments yielded a similar dose-dependent inhibition of CFU-M growth as observed in GM-CSF-induced cultures (Fig. 4) .
Discussion
In this article we studied the influence of IL-4 on colony formation by bone marrow-derived hematopoietic progenitor cells. We observed that colony formation by monocytic precursor cells (CFU-M) was inhibited in a dose-dependent fashion, whereas colony growth of other lineages was not affected. Concentrations of 0 .5 ng IL-4/ml were able to reduce CFU-M growth and profound inhibition was obtained at concentrations higher than 5 ng IL-4/ml.
Inhibition was still seen when a second, nonglycosilated IL-4 preparation was used and could be abrogated by heat inactivation or incubation of the IL-4 with a neutralizing anti-IL-4-antiserum, confirming that this inhibition was due to IL-4 and not to some nonspecific toxic contamination .
The IL-4-induced inhibition of macrophage colony formation was not only seen in cultures of light density and cultures of monocyte-and T cell-depleted bone marrow cells but was still observed on bone marrow cell suspensions enriched ( t 50-fold compared with light density bone marrow cells) for CD34 + HLA-DR' progenitor cells (Fig. 2) . These results suggest a direct effect of IL-4 on monocytic progenitor cells.
The effect of IL-4 on CFU-M growth was not restricted to GM-CSF-stimulated colony growth, but was also observed in M-CSF-stimulated bone marrow cultures . Since colony growth of other lineages was not affected, these findings indicate that inhibition was not caused by interference of IL-4 with the receptors for colony-stimulating factors. We speculate that IL-4, in addition to possible synergism with growth factors such as EPO and G-CSF (3-5), acts directly on hematopoietic progenitor cells by either committing them to nonmonocytic lineages or by blocking the proliferation of monocyte-committed progenitor cells. We favor the latter hypothesis, since inhibition of CFU-M was not accompanied by a compensatory increase in colony formation of other lineages of differentiation . This might well correlate with data from others, describing IL-4-induced differentiation of mononuclear phagocytes (8) (9) (10) (11) .
In conclusion, we describe an IL-4-induced, specific inhibition of macrophage colony formation by bone marrow cells that appears to be exerted directly on the bone marrow progenitor cells. In addition to the production of lineage-specific growth factors, these results imply a mechanism by which hematopoiesis might be regulated in a lineage-specific fashion. To what extent this represents a physiological function of IL-4 remains to be elucidated .
Summary
We investigated the effects of human rIL-4 on in vitro hematopoiesis . A profound inhibition of macrophage colony formation by IL-4 was observed, whereas colony growth of other lineages was not affected . Inhibition of macrophage colony growth was not restricted to GM-CSF-induced colony growth but was also present in cul-tures stimulated with M-CSR This inhibition was not only observed in cultures of light density bone marrow cells, but also in cultures ofmonocyte-and T lymphocytedepleted bone marrow cells. Since a similar inhibition was observed in cultures of CD34''HLA-DR'-enriched bone marrow cells, a direct action of IL-4 on monocyte-committed progenitor cells is suggested .
